LivaNova (LIVN) Non-Current Assets (2015 - 2026)
LivaNova's (LIVN) quarterly Non-Current Assets came in at $1.6 billion in Q2 2026, up 12.17% year-over-year from $1.4 billion in Q2 2025, and up 7.57% quarter-over-quarter from $1.5 billion in Q1 2026.
Analysis
LivaNova (LIVN) Non-Current Assets (2015 - 2026) Analysis & Trends
LivaNova has disclosed Non-Current Assets across 12 years of filings, most recently posting $1.6 billion for Q2 2026.
- In Q2 2026, Non-Current Assets rose 12.17% year-over-year to $1.6 billion; the TTM figure through Jun 2026 stood at $6.1 billion (up 7.92% YoY), while the FY2025 annual figure was $1.5 billion, up 9.08% from the prior year.
- Non-Current Assets came in at $1.6 billion for Q2 2026 at LivaNova, up from $1.5 billion in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $1.6 billion in Q2 2026 to a low of $1.4 billion in Q3 2022.
- Average Non-Current Assets over 5 years is $1.4 billion, with a median of $1.4 billion recorded in 2024.
- Year-over-year, Non-Current Assets slipped 13.4% in 2023 and gained 12.17% in 2026.
- Over 5 years, Non-Current Assets stood at $1.4 billion in 2022, then climbed by 2.33% to $1.4 billion in 2023, then fell by 4.32% to $1.4 billion in 2024, then advanced by 9.08% to $1.5 billion in 2025, then increased by 7.4% to $1.6 billion in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $1.6 billion in Q2 2026, $1.5 billion in Q1 2026, and $1.5 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 8.29 Bn |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn | 1.62 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.62 Bn |
| Mar 31, 2026 | 1.50 Bn |
| Dec 31, 2025 | 1.50 Bn |
| Sep 30, 2025 | 1.46 Bn |
| Jun 30, 2025 | 1.44 Bn |
| Mar 31, 2025 | 1.39 Bn |
| Dec 31, 2024 | 1.38 Bn |
| Sep 30, 2024 | 1.43 Bn |
| Jun 30, 2024 | 1.41 Bn |
| Mar 31, 2024 | 1.42 Bn |
| Dec 31, 2023 | 1.44 Bn |
| Sep 30, 2023 | 1.38 Bn |
| Jun 30, 2023 | 1.40 Bn |
| Mar 31, 2023 | 1.39 Bn |
| Dec 31, 2022 | 1.41 Bn |
| Sep 30, 2022 | 1.36 Bn |
| Jun 30, 2022 | 1.56 Bn |
| Mar 31, 2022 | 1.61 Bn |
| Dec 31, 2021 | 1.52 Bn |
| Sep 30, 2021 | 1.56 Bn |